Elli Papaemmanuil, PhD

Elli Papaemmanuil, PhD

“Investigating the Impact of Oncologic Therapy on Clonal Hematopiesis and Subsequent Risk of Developing Therapy Related Leukemia”

Dr. Papammanuil will study the key risk factors that lead to the therapy related leukemia development in cancer patient survivors. We will combine clinical, molecular and treatment information in a cohort of 45,000 patients to study disease biology and inform guideline development aimed to prevent this aggressive disease.